First Trust NYSE Arca Biotechnology Index Fund
FBT

$169.73

0.07%

Market Cap: $1.17B

0

Funds holding %

of 6,728 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

40% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 25

5.31% more ownership

Funds ownership: 43.23% [Q1] → 48.54% (+5.31%) [Q2]

4% more funds holding

Funds holding: 237 [Q1] → 247 (+10) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

14% less capital invested

Capital invested by funds: $622M [Q1] → $536M (-$86M) [Q2]

34% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 86

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for FBT.

See Analyst Rankings

Financial journalist opinion

Zacks Investment Research

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Zacks Investment Research

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Zacks Investment Research

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Making its debut on 06/19/2006, smart beta exchange traded fund First Trust NYSE Arca Biotechnology ETF (FBT) provides investors broad exposure to the Health Care ETFs category of the market.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Zacks Investment Research

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

FBT: An Equal Weight Way To Play Biotech

Biotech stocks have not regained their 2021 peak levels, making them a potential catch-up trade. First Trust NYSE Arca Biotechnology Index Fund ETF is a fund that replicates the performance of the NYSE Arca Biotechnology Index. The FBT ETF invests equally in 30 leading biotech companies, offering exposure to the sector's growth potential with diversification.

FBT: An Equal Weight Way To Play Biotech

Zacks Investment Research

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a smart beta exchange traded fund launched on 06/19/2006.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Zacks Investment Research

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on 06/19/2006.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Zacks Investment Research

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

The First Trust NYSE Arca Biotechnology ETF (FBT) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Zacks Investment Research

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund launched on 06/19/2006.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Zacks Investment Research

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

See News Rankings